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ABSTRACT 
Desoximetasone chemically is 9-fluoro-IIβ21-dihydroxy-I6a-methylpregna-I.4-diene-3.The precise mechanism of the anti-inflammatory activity 
of topical steroids in the treatment of steroid-responsive dermatoses, in general, is uncertain. So, in present investigation chromatographic 
methods were developing use RP-HPLC for estimation of Desoximetasone in bulk and in cream formulation and method validation according to 
ICH guidelines. The main objective of this study was to develop a simple and reproducible method for desoximetasone by Reverse Phase High 
Performance Liquid Chromatography (RP-HPLC). In this work the desoximetasone separation was carried out by using C18 cosmosile column 
(250mmx4.6mm particle size 5µm). By using 0.1% orthrophosphoric acid pH adjusted up to 3 at uv detection of 240nm.The mobile phase was 
used at various ratio for gradient elution the ratio of mobile phase was 20:80 v/v. Methanol and water used for mobile phase and flow rate was 
being set at 1mL/min. The linearity of proposed method was found in range of r =0.9989. Statistically validation parameters such as linearity, 
accuracy, precision, LOD and LOQ were checked. 
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INTRODUCTION 
Quantitative determination plays important role in several 
scientific field and instruments for chemical analysis are 
highly developed. Quantification depends on comparison of 
signals obtained for the sample with those of analyte 
standard with known concentration and composition. 
Analyte compounds are not easily available for every 
compound. For accurate measurements and analytical 
standards need to have high purity and stability. Purity is 
very essential for analytical standard compound and variety 
of chemical research area 1. Spectroscopy in ultraviolet and 
visible special region is widely used for quantitative 
estimation of organic, inorganic and biological species. Ultra 
violet (UV) and absorption of visible radiation is related with 
excitation of electrons in both atoms and molecules from 
lower to higher energy level. UV spectroscopy in which light 
of ultra violet region is absorbed by molecule. 
Derivative Spectrophotometric Method 2 
Derivative spectrometry in the UV-Vis region is applicable 
method in extracting qualitative and quantitative data by 
overlapping bands of the analyte and interferences. 
Derivative spectroscopy plays very important role in multi-
component analysis of mixture by UV-Vis molecular 
absorption spectrometry under computer controlled. 
Derivative spectrophotometry it is an analytical technique it 
is consist of in the different normal spectrum by 
mathematical transformation of spectral curve into a 
derivative. This method Eliminates the influenced of 
background or matrix and provides more accurate 
fingerprints than traditional or direct absorbance spectra. 
This method improves resolution bands. 
Area Under Curve technique 
AUC method (area under curve) this method is use when 
there is no sharp peak and spectra occurred. This method 
involves calculation of integrated value of absorbance within 
two selected wavelengths.  λ1 and λ2. Area calculation 
processing items find out with the help of area bound with 
curve and horizontal axis. The horizontal axis is selected 
with help of wavelength range in which area has to be 
calculated. According to repeated observation of linearity 
within area under curve and concentration on this basis 
wavelength range is selected. The zero order and first order 
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spectrum were used to calculate AUC. And the calibration 
curve was plotted by concentration versus AUC. 
Concept of chromatography 3 
Chromatography is important biophysical method that 
enables the separation, identification, and purification of 
component of mixture for qualitative and quantitative 
analysis. Chromatography is based on principle where the 
mixture of substances is separated according to their affinity 
towards stationary phase and mobile phase is used for 
elution of separated substance.    
It is based on the two phases 
1. Stationary phase: 
This phase is consisting of solid phase or liquid phase coated 
on surface of solid phase. 
2. Mobile phase: 
This phase is consisting of liquid or gaseous component. 
Technique of chromatography 
1. Ion exchange chromatography  
2. Column chromatography  
3. Affinity chromatography 
4. Thin layer chromatography 
5. Paper chromatography 
6. Gas chromatography 
7. Dye-ligand chromatography 
8. Hydrophobic interaction chromatography 
9. Pseudo affinity chromatography  
10. High pressure liquid chromatography (HPLC) 
Types of chromatography 
a. Adsorption chromatography 
b. Partition chromatography 
c. Size exclusion chromatography 
d. Ion exchange chromatography 
a) Adsorption chromatography4 
The substances in the mixture of analyte are interacting with 
solid stationary phase surface and this substance is 
displaced with eluent. 
b) Partition chromatography 
Partition chromatography it is a thermodynamic distribution 
between two liquids like phases. In this study taking 
consideration of relative polarities of stationary and mobile 
phase. Partition chromatography is divided into normal 
phase and reverse phase chromatography in normal phase 
chromatography, the nature of mobile phase is nonpolar and 
the nature of stationary phase. Polar sample are those on 
which column packing not more than less polar material. In 
the reversed phase chromatography, mobile phase is polar 
liquid, such as mixtures of water and methanol or 
acetonitrile and stationary phase is nonpolar (hydrophobic) 
in nature. In this more nonpolar samples strongly retained. 
c) Size exclusion chromatography 
In this chromatography solute are separated according to 
their molecular size. It includes stationary phase is solid 
with controlled pore size. 
 
d) Ion exchange chromatography 
It includes solid stationary phase containing anionic and 
cationic group on the surface. And in which the solute 
particles of opposite charges are attracted. 
In the analysis of pharmaceutical high-performance liquid 
chromatography (HPLC) and High-performance thin layer 
chromatography (HPTLC) methods are widely used due to 
simplicity, precision, accuracy and reproducibility of results. 
Terms in chromatography 5 
In chromatography the various terms are involved as 
follows. 
 The peak maximum is the highest point of peak. 
 The injection point is that point in which sample is 
placed on column. 
 The dead point is position of peak maximum of 
unretained solute. 
 The dead volume (V0) is the volume of mobile phase 
passed thought the column between the injection point 
and the dead point. Thus, V0 = Qt0 where Q is the flow 
rate in ml/min and t0 is dead time. 
 The retention time (tR) it is time interval between the 
injection point and the peak maximum. Each solute has a 
characteristic retention time. 
 The retention volume (VR) is the volume of mobile phase 
passed through the column between the injection point 
and the peak maximum Thus, VR = QtR where Q is the 
flow rate in ml/min and tR is retention time. Each solute 
will also have a characteristic retention volume. 
 The corrected retention time(t'R) is the time elapsed 
between the dead point and the peak maximum 
 The corrected retention value (V'R) is the volume of 
mobile phase transfer through the column between the 
dead point and the peak maximum It will also be the 
retention volume minus the dead volume Thus, VR=VR-
V0=Q where Q is the flow rate in ml/min. 
 The peak height (it is the distance between the peak 
maximum and the base line geometrically produced 
beneath the peak. 
 The peak width at half height (W0.5) is the distance 
between each side of a peak measured at half of the peak 
height. There is no significance and peak width 
measured at half height with chromatographic theory. 
 The peak width at the base (Wb) is the distance between 
the intersections of the tangents drawn to the sides of 
the peak and the peak base geometrically produced  
 The peak width has significance in chromatographic 
theory and peak width is equivalent four standard 
deviation. 
The standard analytical procedure of newer drug may not be 
available in pharmacopoeia hence it is essential to developed 
analytical method validation such as linearity, accuracy, 
precision, sensitivity.[8] The chemical name of 
Desoximetasone is 9a-fluro-11ß,21-dihydroxy-16a-methyl 
pregna-1,4diene 3,20-dione. It is used as anti-inflammatory 
agent corticosteroid and dermatological preparations 6. It is 
topical corticosteroids represent the treatment of choice for 
numerous different inflammatory skin diseases, in particular 
atopic eczema. [10] In present study the new method was 
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developed methanol as a solvent in HPLC. It is the simple 
method for desoximetasone separation from mixture of 
compound. 
Drug profile 
Desoximetasone Structure 7 
 
Figure 1: Desoximetasomne Structure 
MATERIALS AND METHOD 9 
Methanol and orthrophosphoric acid were used as HPLC 
grade. All reagents were used as analytical grade and reverse 
osmosis, ultra-pure water, water purification system, 
sonicator, filtration assembly and pure drug of 
desoximetasone drug. 
Chromatographic system 
The RP-HPLC system composed of Agilent 1200 series 
instant pilot software: Chemstation Plus and certified for 
pharmaceutical QA/QC. It constitutes micro vacuum 
degasser G1379B, binary pump G1312B, variable 
wavelength detector SL G1315C, thermostatted column 
compartment G1316B with C18 column [4.6x250mm, pore 
size 5μm], high performance auto sampler G1367C, 
thermostat for high performance auto sampler G1330B. It is 
most flexible configuration for the maximum in gradient and 
low flow rate accuracy and precision, high-speed, 
multiwavelength and full spectral UV-visible detection for 
peak purity analysis and spectral confirmation. 
Chromatographic condition  
The mobile phase prepared by using two solvent containing 
methanol and water filter through 0.5µm filter paper (pH 
adjusted to 3 with 0.1% orthrophosphoric acid). Degassed 
the mixture with sonication. The detection was carried out at 
240nm by using variable wavelength detector. 
Preparation of standard stock solution 
Stock solution was prepared by dissolving 10mg of 
desoximetasone in 10 ml of methanol that gives 
concentration of 100µg/ml of desoximetasone. 
Preparation of mobile phase 
For the preparation of mobile phase methanol and water 
were used. The ratio of mobile phase was 20:80v/v. filtrated 
the mobile phase by using 0.5µm size of filter paper. Then 
sonicated that mixture for 15 min. and added 0.1% 
orthrophosphoric acid. And these mixture of solvent used as 
mobile phase. 
Optimization of Method 
The main aim of the HPLC method is to develop and 
validation of desoximetasone. There are different mobile 
phases were tried for the method development but good 
resolution observed with methanol and water. PH adjusted 
up to the 3 by using orthrophosphoric acid. C18 column 
(250mmx4.5mm particle size 5µm) was used. 
 
Table 1: Optimization of Method 
Chromatographic Mode  Chromatographic Condition 
HPLC system  Agilent 
Pump Gradient 
Detector  Wavelength variable detector 
Data processor Chemstation software 
Stationary phase C18 column cosmosile (250mmx4.6mmx5µm) 
Mobile phase  Water: Methanol (20:80v/v) pH adjusted up to 3 with OPA) 
Detection of wavelength 240nm 
Flow rate (mL/min) 1.0 
Sample size 20µl. 
 
 
Figure 2: Chromatogram of desoximetasone showing retention time 4.5 min 
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Validation of method 13 
Validation of optimize method was carried out by following 
parameters. 
Linearity 
From stock solution of desoximetasone 0.3-1.8ml 
concentration were taken in 10 ml. volumetric flask diluted 
up to the mark with mobile phase such that final 
concentration of desoximetasone in the range of 3-18µg/ml. 
volume of 20µl of each sample solution was injected with the 
help of syringe all measurement was repeated for three 
times for each concentration and standard calibration curve 
were plotted peak area vs concentration. 
 
 
Figure 3:  Linearity curve of Desoximetasone 
 
Table 2: Linearity study of desoximetasone 
Parameters Desoximetasone 
Linearity range (µg/ml) 3-18  
Slope  659148 
Intercept 565722 
Correlation coefficient(r2) 0.9982 
 
Analysis of bulk formulation  
Accurately weighed 10 mg of desoximetasone dissolved in 10 
ml of methanol. And the solution was diluted with the 
prepared mobile phase and this method is subjected for the 
proposed method amount of desoximetasone calculated by 
linear regression equation and the same concentration was 
repeated for six times. 
 
Table 3: Analysis of bulk formulation Study 
Sr.no Amount taken Amount Found 
(µg/ml) 
% Amount Found 
± SD 
% RSD 
1. 12 11.99 99.22 ±0.60 0.603 
 
Analysis of cream formulation 11 
Determined the content of desoximetasone in marketed 
cream (label claim 0.25% of desoximetasone 10mg/ml) 
10gm cream was weighed and average weight was 
calculated. The drug was dissolved in 100ml methanol and 
the extraction was sonicated for 15 min and centrifuge at 
300rpm.Then 1ml solution from it was diluted with 10 ml 
mobile phase. The resulting solution was injected in HPLC 
and drug peak area was noted. The peak area regression 
equation and amount of desoximetasone in sample was 
calculated. 
 
Table 4: Analysis of cream formulation Study 
Sr.no Amount 
taken 
Amount Found 
(µg/ml) 
% Amount Found ± SD % RSD 
1 12 11.96 99.69 ± 1.93 1.94 
 
Accuracy 
Accuracy was done by recovery study using standard 
addition of method at 80%,100%, and 120% level known 
amount of desoximetasone standard was added to 
reanalyzed sample and subjected them to the proposed HPLC 
method. Results are shown in below. 
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Table 5: Recovery study 
Sr. no Initial 
amount 
(µg/ml) 
Amount of 
standard drug 
added 
(µg/ml) 
Amount of 
drug added 
% 
Amount 
Recovered 
(µg/ml) 
%Drug Recovered 
Mean ± SD 
% RSD 
1 9 7.2 80 16.21 99.85 ± 0.27 1.69 
2 9 9.0 100 18.07 100.40 ±0.14 0.82 
3 9 10.8 120 19.77 99.87 ±0.19 0.99 
 
Precision  
The precision study was carried out by including the 
repeatability study Inter day and intraday precision. 
Repeatability study was carried out by injecting 2µg/ml. 
concentration for six times and intraday precision was 
carried out by analyzing one concentration in different time 
period of same day. Inter day precision study was carried 
out by injecting the one concentration in different day of 
varies in time period. 
 
Table 6: Precision study 
Precision Amount taken 
(µg/ml) 
Amount Found 
(µg/ml) 
% Amount Found 
(µg/ml) 
Mean ± SD 
% RSD 
Repeatability 
(n=6) 
12 11.99 99.94 ±0.78 0.78 
Intraday 
(n=6) 
9 11.90 99.28 ± 2.88 1.31 
12 11.94 99.77 ±2.83 1.52 
15 11.95 99.81 ±2.81 1.58 
Inter day 
(n=6) 
9 11.89 99.20 ±2.90 1.48 
12 11.95 99.81 ±2.85 1.27 
15 11.96 99.99 ±2.78 1.82 
 
Limit of Detection (LOD) and Limit of Quantification 
(LOQ) 
Limit of detection is the lowest amount of analyte in sample 
which can be detected but not necessarily quantitated as an 
exact value. Formula for LOD is 3.3σ/s and LOQ is the lowest 
amount of analyte in sample that can be quantitatively 
determined by suitable accuracy and precision. Formula for 
LOQ is 10 σ/s. 
Table 7: Sensitivity Study 
LOD (µg/ml) 0.31 
LOQ (µg/ml) 0.95 
 
Table 8: Ruggedness Study 
The ruggedness analysis was done by two different analysts on the environmental condition. These analyses were done by six 
time of same concentration by different analyst. 
Amount taken 
(µg/ml) 
Analyst –I (n=6) Analyst –II (n=6) 
 Amount 
found 
% Amount 
found ± SD 
% RSD Amount found % Amount found 
± SD 
% RSD 
12 11.94 99.54 ± 1.38 1.39 12.02 100.18 ± 0.79 0.65 
 
CONCLUSION 
RP-HPLC method it is a simple precise and accurate method 
was developed and validated for routine analysis for 
desoximetasone in bulk and cream formulation. The 
proposed method could be successfully applied for the 
routine analysis and quality control of dosage form 
containing desoximetasone.   
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